Welcome on the contact form of the press room at Inserm.
Journalists, please feel free to contact us directly: rf.mresni@bew-esserp
If you want information about Inserm and you are not a journalist, thank you to click here.
Nirsevimab is an antibody targeting the respiratory syncytial virus (RSV). Available in France since September 2023, it is indicated in neonates and infants for the prevention of bronchiolitis caused....
Macrophages, key cells of the immune system, play a central role in cleaning the body by ingesting and destroying pathogens (bacteria, viruses, etc.) and damaged cells. Scientists from Inserm,....